Page last updated: 2024-10-25

deferoxamine and Temporomandibular Disorders

deferoxamine has been researched along with Temporomandibular Disorders in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, MC1
Kawai, Y1
Shoji, H1
Yoshino, F1
Miyazaki, H1
Kato, H1
Suga, M1
Kubota, E1

Other Studies

1 other study available for deferoxamine and Temporomandibular Disorders

ArticleYear
Evidence of reactive oxygen species generation in synovial fluid from patients with temporomandibular disease by electron spin resonance spectroscopy.
    Redox report : communications in free radical research, 2004, Volume: 9, Issue:6

    Topics: Adolescent; Adult; Deferoxamine; Electron Spin Resonance Spectroscopy; Female; Humans; Hydroxyl Radi

2004